Inhibition of wound-induced expression of transforming growth factor-β1 mRNA by its antisense oligonucleotides

Pharmacological Research

Volumn 37, Issue 4, 1998, Pages 289-293

  Kim, Hyung Min ^a   Choi, Dong Hyuk ^a   Lee, Young Mi ^a  

^a Wonkwang University   (South Korea)

Author keywords

Antisense oligonucleotide; Transforming growth factor 1; Wound

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; WOUND;

EID: 0032055315     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0300     Document Type: Article

References (28)

1. 1. Hill DJ, Strain AJ, Elstow SF, Swenne I, Milner RD. Bifunctional action of transforming growth factor β on DNA synthesis in early passage human fetal fibroblasts. J Cell Physiol 1986; 322: 322-8.
2. 2. Moses HL, Tucker RF, Leof EB, Coffey RJ, Haiper J, Shipley GD. Type-β transforming growth factor is a growth stimulator and growth inhibitor. Cancer Cells 1985; 3: 65-71.
3. 3. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stein DF, Sporn MB. Type β transforming growth factor: a bifunctional regulator of cell growth. Proc Natl Acad Sci USA 1985; 82: 119-23.
4. 4. Shipley GD, Pittelkow MR, Wille JJ, Scott RE, moses HL. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum free medium. Cancer Res 1986; 46: 2068-71.
5. 5. Roberts AB, Sporn MB, Assolan RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga J, Kehrle JH, Fauci AS. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-71.
6. 6. Ignotz RA, Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen in their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-45.
7. 7. Merwin JR, Anderson JM, Kocher O, Van Italie CM, Madri JA. TGF β1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 1990; 142: 117-28.
8. 8. Vollberg TM, George MD, Jetten AM. Induction of extracellular matrix gene expression in normal human keratinocytes by TGFβ is altered by cellular differentiation. Exp Cell Res 1991; 193: 93-100.
9. 9. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987; 165: 251-6.
10. 10. Wahl SM, Hunt DA, Wakefield LM, McCartney FN, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84: 5788-92.
11. 11. Ksander GA, Ogawa Y, Chu GH, McMullin H, Rosenblatt JS, McPherson JM. Exogenous TGFβ2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann Surg 1990; 211: 288-94.
12. 12. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and induction activities in a rabbit dermal ulcer model. J Clin Invest 1991; 87: 694-703.
13. 13. Pierce GF, Vande-Berg J, Rudolph R, Tarpley J, Mustoe TA. Platelet-derived growth factor-BB and transforming growth factor β1 selectively modulate glycosaminoglycans, collagen and myofibroblasts in excisional wounds. Am J Pathol 1991; 138: 629-46.
14. 14. Hebda PA. Stimulatory effects of transforming growth factor-β and epidermal growth factor and epidermal cell outgrowth form porcine skin expiant cultures. J Invest Dermatol 1988; 91: 440-5.
15. 15. Nickoloff BJ, Mitra RS, Riser BL, Dixit VM, Vanasi J. Modulation of keratinocyte motility correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol 1988; 132: 543-51.
16. 16. Akhurst RJ, Fee F, Balmain A. Localized production of TGFβ mRNA in tumor promoter-stimulated mouse epidermis. Nature 1988; 331: 363-5.
17. 17. Kane CJ, Knapp AM, Mansbridge JM, Hanawalt PC. TGFβ1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 1990; 144: 144-50.
18. 18. Helene C, Toulme JJ. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99-125.
19. 19. Thierry AR, Rahman A, Dritschilo A. Liposomal delivery as a new approach to transport antisense oligonucleotides. In: Erickson R, Izant JG, eds. Gene Regulation: Biology of Antisense RNA and DNA. New York: Raven Press Ltd., 1992: pp. 147-61.
20. 20. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-β precursor. J Biol Chem 1986; 262: 4377-9.
21. 21. Kim HM, Hirota S, Chung HT, Ohno S, Osada SI, Shin TK, Ko KI, Kim JB, Kitamura Y, Nomura S. Differential expression of protein kinase C genes in cultured mast cells derived from normal and mast cell-deficient mice and mast cell lines. Int Arch Allergy Immunol 1994; 105: 258-63.
22. 22. Kim HM, Hirota S, Hitoshi O, Hirata T, Suzuki K, Ohno S, Kuroki T, Kitamura Y, Nomura S. Localization and developmental expression of a novel protein kinase C δ gene. Dev Brain Res 1992; 70: 239-44.
23. 23. Sporn MB, Roberts AB, Wakefield LM, Assosian RK. Transforming growth factor β: biological function and chemical structure. Science 1986; 233: 532-4.
24. 24. Simons M, Edelman ER, Dekeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992; 359: 67-70.
25. 25. Cohen JS. Oligodeoxynucleotides: antisense inhibitors of gene expression. In: Topics in Molecular and Structural Biology. Vol. 12. London: Macmillan Press Ltd, 1989.
26. 26. Hall TJ, Brostoff J. Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (oligostick). Immunology 1992; 77: 462-4.
27. 27. Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA 1987; 84: 7696-700.
28. 28. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing: single and synergistic effects on partial thickness porcine sin wounds. J Clin Invest 1989; 84: 640-6.